191 related articles for article (PubMed ID: 25472670)
1. Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.
Ristau J; Staffa J; Schrotz-King P; Gigic B; Makar KW; Hoffmeister M; Brenner H; Ulrich A; Schneider M; Ulrich CM; Habermann N
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2632-7. PubMed ID: 25472670
[TBL] [Abstract][Full Text] [Related]
2. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
[TBL] [Abstract][Full Text] [Related]
3. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
4. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery.
Rotelli MT; Di Lena M; Cavallini A; Lippolis C; Bonfrate L; Chetta N; Portincasa P; Altomare DF
Int J Colorectal Dis; 2015 Jul; 30(7):891-8. PubMed ID: 25989926
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
8. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
10. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
13. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
15. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
16. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-34a levels are reduced in colorectal cancer.
Nugent M; Miller N; Kerin MJ
J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as Promising Tumor Biomarkers.
Chen M; Calin GA; Meng QH
Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
[TBL] [Abstract][Full Text] [Related]
19. Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.
Miotto E; Saccenti E; Lupini L; Callegari E; Negrini M; Ferracin M
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2638-42. PubMed ID: 25472671
[TBL] [Abstract][Full Text] [Related]
20. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]